102 related articles for article (PubMed ID: 8841436)
1. c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.
Borrè A; Cultraro CM; Segal S
J Cell Physiol; 1996 Oct; 169(1):200-8. PubMed ID: 8841436
[TBL] [Abstract][Full Text] [Related]
2. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
[TBL] [Abstract][Full Text] [Related]
3. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
4. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
[TBL] [Abstract][Full Text] [Related]
7. Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells.
Nguyen HQ; Selvakumaran M; Liebermann DA; Hoffman B
Oncogene; 1995 Dec; 11(11):2439-44. PubMed ID: 8570196
[TBL] [Abstract][Full Text] [Related]
8. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
10. Specific c-myc and max regulation in epithelial cells.
Martel C; Lallemand D; Crémisi C
Oncogene; 1995 Jun; 10(11):2195-205. PubMed ID: 7784064
[TBL] [Abstract][Full Text] [Related]
11. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
13. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
[TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
Larsson LG; Bahram F; Burkhardt H; Lüscher B
Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
[TBL] [Abstract][Full Text] [Related]
17. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
[TBL] [Abstract][Full Text] [Related]
19. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.
Peverali FA; Orioli D; Tonon L; Ciana P; Bunone G; Negri M; Della-Valle G
Oncogene; 1996 Jan; 12(2):457-62. PubMed ID: 8570225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
